Catalyst Pharmaceutical CPRX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Catalyst Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's total current liabilities?
- Catalyst Pharmaceutical (CPRX) reported total current liabilities of $132.4M in Q1 2026.
- How has Catalyst Pharmaceutical's total current liabilities changed year-over-year?
- Catalyst Pharmaceutical's total current liabilities increased by 18.6% year-over-year, from $111.65M to $132.4M.
- What is the long-term trend for Catalyst Pharmaceutical's total current liabilities?
- Over 5 years (2020 to 2025), Catalyst Pharmaceutical's total current liabilities has grown at a 45.3% compound annual growth rate (CAGR), from $22.76M to $147.15M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.